IP Verse

Anti Ifnar1 Dosing Regime For Subcutaneous Injection - EP4114465

PATENT ANALYSIS

Patent Details

Grant Date
Aug 30, 2023
Company
ASTRAZENECA AB
Oppositions

MAIWALD GMBH

More patents of Astrazeneca Ab

EP3045466

EP4114465

EP2508188

Want to monitor this patent?

Feel free to send us a message here and we will get back to you